TALIS BIOMEDICAL CORP - COM (TLIS)

CUSIP: 87424L108

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
12,603,598
Share change
-2,305,130
Total reported value
$8,590,382
Price per share
$0.68
Number of holders
21
Value change
-$1,624,267
Number of buys
3
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 87424L108?
CUSIP 87424L108 identifies TLIS - TALIS BIOMEDICAL CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TALIS BIOMEDICAL CORP - COM (TLIS) as of Q3 2022

As of 30 Sep 2022, TALIS BIOMEDICAL CORP - COM (TLIS) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,603,598 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, GREENLIGHT CAPITAL INC, ArrowMark Colorado Holdings LLC, VANGUARD GROUP INC, PRELUDE CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., MERCER GLOBAL ADVISORS INC /ADV, and MORGAN STANLEY. This page lists 21 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.